Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Moderna to Build Vaccine Facility in Quebec

Stockhouse Editorial
0 Comments| May 2, 2022

{{labelSign}}  Favorites
{{errorMessage}}

Commercial-stage biotech outfit Moderna Inc. (NASDAQ: MRNA, Forum) is going to build a state-of-the-art mRNA vaccine manufacturing facility in Quebec that will support a long-term strategic partnership with the Government of Canada to enhance pandemic preparedness.

Moderna’s Chief Executive Officer, Stéphane Bancel spoke on this news in a media statement and called Canada an ideal candidate for an onshore vaccine manufacturing facility.

“This partnership is designed to provide Canadians with access to Moderna's vaccines in future pandemics and health emergencies.”

Once operational, the facility is expected to provide access to a domestically manufactured portfolio of mRNA vaccines against respiratory viruses, including COVID-19, seasonal influenza, respiratory syncytial virus (RSV), and other potential respiratory viruses, contingent on approval by Health Canada. In the event of a future pandemic, it is also expected that the facility could be activated on an urgent basis to support Canada with direct access to rapid pandemic response capabilities with the capacity to adapt and adjust manufacturing to address novel or emerging viruses.



{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today